EU Regulatory Update: Where Do We Stand Now – On Shaky Ground?
Executive Summary
Most EU regulators are now back in the swing of work after their summer break and the conference season is heating up. What are the key issues likely to top the agenda over the next few months?
You may also be interested in...
Will New EU Standards Crisis Management Disrupt Industry's MDR Efforts?
Some of the EU's most critical medtech standards have been coming under criticism for more than half a decade. Now, the European Commission is making key changes, but the timing could not be worse for the sector.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.